Stock listing

Oslo:ONCIN Oncoinvent ASA Aksje

Home listing (Oslo) of Oncoinvent ASA

Follow Oncoinvent ASA into a list and get an email when it puts out news.

Share price · OSL:ONCIN

68.20 NOK +0.20 (+0.3%)

Close on Oct 16, 2026

Since Jul 6, 2026 +32.7% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
66.80 – 71.60 NOKOct 16, 2026
Volume
17,997 sharesOct 16, 2026
Market value
418.0M NOKAt the close on Oct 16, 2026 · price × 6.13M shares outstanding
Oncoinvent ASA logo
Ticker
Oslo:ONCIN
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Oslo
Currency
NOK

What changed lately

Calls

Replays

  • Oncoinvent (Oslo:ONCIN) Q4 2025 Earnings Call

    Thu, Feb 26, 2026 · 4:30 AM ET

    Watch Transcript

  • Oncoinvent (Oslo:ONCIN) Q3 2025 Earnings Call

    Tue, Nov 04, 2025 · 4:00 AM ET

    Watch Transcript

  • Oncoinvent (Oslo:ONCIN) Q4 2024 Earnings Call

    Wed, Feb 26, 2025 · 4:30 AM ET

    Watch Transcript

Latest news

Oncoinvent ASA - Disclosure of large shareholding

Sep 23, 2026

Oncoinvent ASA - Mandatory notification of trade - Allocation and share lending in Private Placement

Sep 22, 2026

Oncoinvent ASA - Mandatory notification of trade

Sep 22, 2026

Oncoinvent ASA - Key information relating to subsequent offering

Sep 22, 2026

Oncoinvent ASA - Successful Private Placement and Retail Offering

Sep 22, 2026

Oncoinvent ASA - Contemplated private placement and retail offering

Sep 22, 2026

Oncoinvent announces publication of normal tissue dosimetry results in Journal of Nuclear Medicine

Aug 11, 2026

Oncoinvent achieves 50% recruitment milestone in Phase 2 ovarian cancer study of Radspherin[®]

Jun 18, 2026

Oncoinvent ASA: Grant of share options to member of the Board following AGM

May 20, 2026

Oncoinvent ASA: Share capital decrease completed

May 5, 2026

All Oncoinvent ASA news

Financings

  • Private placement of new shares

    Sep 22, 2026 · US$14.59M

    Closed: NOK 137.8M raised · NOK 90 a share · ABG Sundal Collier ASA +1

    Dealers: ABG Sundal Collier ASA (co-lead), DNB Carnegie (co-lead)

    Buyers: Linc AB (Offer Shares for NOK approximately 17.4 million); Hadean Ventures (Offer Shares for approximately NOK 17.3 million); Øystein Soug (Offer Shares for NOK 299,970); Ramzi Amri (Offer Shares for NOK 270,000); Gillies O'Bryan-Tear (Offer Shares for NOK 886,140); Gro Hjellum (Offer Shares for NOK 45,000); Ingrid Akay (Offer Shares for NOK 358,560); Kari Grønås (Offer Shares for NOK 29,880); Hadean Capital I AS (108,469 new shares); HVentures Capital I AB (49,199 new shares); Hadean Growth Fund I AS (34,875 new shares)

    Insiders: Hadean Capital I AS, HVentures Capital I AB and Hadean Growth Fund I AS, closely associated with board member Ingrid Teigland Akay, were allocated 192,543 new shares in aggregate

    Use of proceeds: Progress and complete Phase 2 ovarian cancer study, FDA/EMA regulatory alignment and Phase 3 IND/CTA submission, Phase 3 readiness

    Announced Sep 22, 2026 · Closed Sep 22, 2026 · Update Sep 22, 2026

  • New shares (subsequent repair offering)

    Sep 22, 2026

    Update: NOK 90 a share

    Announced Sep 22, 2026 · Update Sep 22, 2026

  • New shares (retail offering)

    Sep 22, 2026 · US$1.13M

    Closed: NOK 10.7M raised · Nordnet Bank AB

    Dealers: Nordnet Bank AB

    Announced Sep 22, 2026 · Closed Sep 22, 2026

Read by 6ix AI from the company's releases

Decks

Oncoinvent ASA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
29 in the last 12 months · 32 in all · newest Sep 23, 2026 · oldest 2025
Calls
6 calls with a replay · 6 with a transcript · latest Feb 26, 2026
Decks
21 decks · latest September 2026

Where Oncoinvent ASA is listed

ListingExchangeCountryCurrency
Oslo:ONCIN · Home listing · This pageOsloNorwayNOK
LS Exchange:A41YN5LS ExchangeGermanyEUR
Lang & Schwarz:A41YN5Lang & SchwarzGermanyEUR
LSE:0RU5LSEUnited KingdomNOK
OTC:BRRGFOTCUnited StatesUSD
gettex:7BGgettexGermanyEUR
Aquis:ONCINOAquisUnited KingdomNOK
Aquis:ONCINOAquisUnited KingdomNOK
Dusseldorf:7BGDusseldorfGermanyEUR
Frankfurt:7BGFrankfurtGermanyEUR
Munich:7BGMunichGermanyEUR
Stockholm:ONCINOStockholmSwedenNOK
Stuttgart:7BGStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Oncoinvent ASA.